Evidence map›Paper›PMID 31904386›Full record

ArticleExperimental neurology2020

Cuprizone-induced demyelination under physiological and post-stroke condition leads to decreased neurogenesis response in adult mouse brain.

Fucheng Luo, Zhen Zhang, Austin Barnett, Tania J Bellinger, Flavia Turcato, Kelly Schmidt, Yu Luo

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fucheng LuoDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, USA.
Zhen ZhangDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, USA.
Austin BarnettDepartment of Neurological Surgery, Case Western Reserve University, Cleveland, USA.
Tania J BellingerDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, USA.
Flavia TurcatoDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, USA.
Kelly SchmidtDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, USA.
Yu LuoDepartment of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, USA. Electronic address: luoy2@ucmail.uc.edu.
University of Cincinnati · USCase Western Reserve University · US

Funding

Genetic and drug modulation of sonic hedgehog pathway in brain ischemiaR01NS091213 · NINDS · UNIVERSITY OF CINCINNATI · PI LUO, YU · 2015 to 2019
$1.7M
Modulating a critical inhibitory proteoglycan receptor to promote functional recovery after strokeR01NS107365 · NINDS · UNIVERSITY OF CINCINNATI · PI LUO, YU, SILVER, JERRY · 2019 to 2022
$1.4M
NINDS NIH HHS R01 NS091213NINDS NIH HHS R01 NS107365
6 · The paper itself

Abstract

Due to the limitation in treatment window of the rtPA (recombinant tissue plasminogen activator), the development of delayed treatment for stroke is needed. We previously reported that there is a difference in neurogenesis and neuroblast migration patterns in different mouse stroke models (proximal and distal middle cerebral artery occlusion models, pMCAo or dMCAo). Specifically, compared to robust neurogenesis and substantial migration of newly born neuroblasts in pMCAo model, dMCAo only illicit limited neurogenesis and migration of neuroblasts towards ischemic area. One potential reason for this difference is the relative location of ischemic area to white matter and the neurogenic niche (subventricular zone, SVZ). Specifically, white matter could serve as a physical barrier or inhibitory factor to neurogenesis and migration in the dMCAo model. Given that a major difference in human and rodent brains is the content of white matter in the brain, in this study, we further characterize these two models and test the important hypothesis that white matter is an important contributing inhibitory factor for the limited neurogenesis in the dMCAo model. We utilized a genetically inducible NSC-specific reporter mouse line (nestin-CreERT2-R26R-YFP) to label and track NSC proliferation, survival and differentiation in ischemic brain. To test whether myelin is inhibitory to neurogenesis in dMCAo model, we demyelinated mouse brains using cuprizone treatment after stroke and examined whether there is enhanced neurogenesis or migration of neuroblasts cells in stroke mice treated with cuprizone. Our data suggests that demyelination of the brain does not result in enhanced neurogenesis or migration of neuroblasts, supporting that myelin is not a major inhibitory factor for stroke-induced neurogenesis. In addition, our results suggest that in non-stroke mice, demyelination causes decreased neurogenesis in adult brain, indicating a potential positive role of myelin in maintenance of adult neural stem cell niche.

Indexed as

Chelating AgentsCuprizoneAnimalsBehavior, AnimalBrain IschemiaCell DifferentiationCell MovementCell ProliferationCell SurvivalDemyelinating DiseasesMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLNeural Stem CellsNeurogenesisChelating AgentsCuprizoneDistal MCAoNeurogenesisProximal MCAoStrokeWhite matter

Identifiers

PMID31904386
PMCPMC9694109
OpenAlexW2996963173

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.